Juerg Lehmann
Impact in
-
- Diabetes Treatment and Management
- Diet, Metabolism, and Disease
-
- Neuropeptides and Animal Physiology
Papers in
-
- Receptor Mechanisms and Signaling 3
- RNA and protein synthesis mechanisms 1
- RNA modifications and cancer 1
-
- Synthesis and Characterization of Heterocyclic Compounds 1
- Inorganic and Organometallic Chemistry 1
- Co-authors
- Daniel J. Buzard (3 shared papers)James Leonard (2 shared papers)Robert M. Jones (4 shared papers)Christoffer Norn (2 shared papers)Stephen J. Lippard (1 shared paper)M. Hauge (2 shared papers)Thue W. Schwartz (2 shared papers)Kenneth G. Strothkamp (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of Medicinal Chemistry (1 paper)Expert Opinion on Therapeutic Patents (1 paper)Future Medicinal Chemistry (1 paper)British Journal of Pharmacology (1 paper)
- Partner nations
- United StatesDenmarkGermany
In The Last Decade
Juerg Lehmann
13 papers receiving 238 citations
Peers
Comparison fields: 5 of 47
- Endocrinology, Diabetes and Metabolism 126
- Cellular and Molecular Neuroscience 48
- Molecular Biology 124
- Surgery 71
- Endocrine and Autonomic Systems 10
Countries citing papers authored by Juerg Lehmann
This map shows the geographic impact of Juerg Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juerg Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juerg Lehmann more than expected).
Fields of papers citing papers by Juerg Lehmann
This network shows the impact of papers produced by Juerg Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juerg Lehmann. The network helps show where Juerg Lehmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Juerg Lehmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 125 | |
| 2 | 2011 | 39 | |
| 3 | 2014 | 25 | |
| 4 | 2014 | 13 | |
| 5 | 1978 | 13 | |
| 6 | 2012 | 8 | |
| 7 | 2015 | 7 | |
| 8 | 2009 | 6 | |
| 9 | 2024 | 5 | |
| 10 | 2025 | 4 | |
| 11 | EPC-Synthese, Struktur und Pharmakologie lactonisierter und lactamisierter Acetylcholin-Analoga : Lactone. XXVIII | 1995 | 1 |
| 12 | 1997 | 1 | |
| 13 | LE300--new results on its ability to antagonize the discriminative stimulus effects of cocaine. | 2006 | 1 |
About Juerg Lehmann
Juerg Lehmann is a scholar working on Molecular Biology, Organic Chemistry, Cellular and Molecular Neuroscience, Endocrinology, Diabetes and Metabolism and Surgery, having authored 13 papers that have together received 248 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (3 papers), Receptor Mechanisms and Signaling (3 papers), Neurotransmitter Receptor Influence on Behavior (2 papers), Diabetes Management and Research (1 paper), RNA and protein synthesis mechanisms (1 paper), RNA modifications and cancer (1 paper), Synthesis and Characterization of Heterocyclic Compounds (1 paper) and Inorganic and Organometallic Chemistry (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (126 citations), Cellular and Molecular Neuroscience (48 citations), Molecular Biology (124 citations), Surgery (71 citations) and Endocrine and Autonomic Systems (10 citations). Juerg Lehmann has collaborated with scholars based in United States, Denmark and Germany. Frequent co-authors include Daniel J. Buzard, James Leonard, Robert M. Jones, Christoffer Norn, Stephen J. Lippard, M. Hauge, Thue W. Schwartz, Kenneth G. Strothkamp, Maja S. Engelstoft and Thomas M. Frimurer. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Expert Opinion on Therapeutic Patents, Future Medicinal Chemistry and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.